Premier Cannabis (WA)

Premier Cannabis (WA) concentrated 77.31% of September 2026 sales in Flower with 135.42% year-over-year growth and 7.39% month-over-month, while Concentrates held 21.23% share with 67.90% year-over-year and 20.31% month-over-month; Vapor Pens shrank to 1.46% share with -27.42% year-over-year and -12.15% month-over-month. Against a brand-level 110.53% year-over-year sales lift and a 9.19% year-over-year average price increase to $38.94, Flower’s faster expansion and higher $40.82 average price point indicate mix-driven uplift, whereas Vapor Pens’ contraction acts as a drag; the pattern implies the brand’s current growth is anchored in WA Flower, with Concentrates emerging as the incremental volume engine.

With Flower at rank 46 in Washington and accounting for over three-quarters of mix, the 7.39% month-over-month gain alongside Concentrates’ 20.31% month-over-month rise suggests depth in core inhalables but a narrowing footprint in Vapor Pens at -12.15% month-over-month. Given Flower’s 135.42% year-over-year outpacing the brand’s 110.53% and Concentrates’ 67.90%, the portfolio is tilting toward higher-priced Flower while de-emphasizing Pens at a 1.46% share; this positioning implies near-term share stability via Flower price realization with headroom to move up from rank 46 if Concentrates scale continues and Vapor Pens are treated as a deliberate deprioritization rather than a growth lane.